<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11864862</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1280</article-id><article-id pub-id-type="other">EPV0615</article-id><article-id pub-id-type="pii">S092493382401280X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Reduced resting-state gamma-band power correlate with unaltered glutamate + glutamine levels in patients at clinical-high risk of psychosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tomyshev</surname><given-names>A. S.</given-names></name><xref rid="aff2864" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lebedeva</surname><given-names>I.</given-names></name><xref rid="aff2864" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Dudina</surname><given-names>A.</given-names></name><xref rid="aff2864" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1134" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Menshchikov</surname><given-names>P.</given-names></name><xref rid="aff2865" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kupriyanov</surname><given-names>D.</given-names></name><xref rid="aff2865" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Omelchenko</surname><given-names>M.</given-names></name><xref rid="aff2866" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff2864"><sup>1</sup>Laboratory of Neuroimaging and Multimodal Analysis, <institution>Mental Health Research Center</institution></aff><aff id="aff2865"><sup>2</sup>Clinical Science, <institution>LLC Philips Healthcare Russia</institution></aff><aff id="aff2866"><sup>3</sup>Department of youth psychiatry, <institution>Mental Health Research Center</institution>, <city>Moscow</city>, <country>
Russian Federation</country></aff><author-notes><corresp id="cor1134"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1255">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S615</fpage><lpage>S615</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382401280Xa.pdf"/><abstract><sec id="sec6817"><title>Introduction</title><p>There is growing evidence of excitation / inhibition (E/I) balance abnormalities in schizophrenia, which might be associated with abnormal gamma frequency oscillations and glutamate concentrations. However, to the best of our knowledge, only one multimodal study have examined such associations between EEG and metabolite characteristics in patients at clinical-high risk of psychosis (CHR) so far.</p></sec><sec id="sec6818"><title>Objectives</title><p>We aimed to investigate potential associations between GLX (glutamate + glutamine) levels and resting-state gamma-band power in CHR individuals and healthy controls (HC).</p></sec><sec id="sec6819"><title>Methods</title><p>Twenty right-handed male patients (16-27 years, mean age 19.9 &#x000b1; 2.7) fulfilling CHR criteria and 19 healthy male controls (16-27 years, mean age 21.6 &#x000b1; 3.6) underwent resting-state EEG (16 leads; 10&#x02212;20 system) and MR spectroscopy at 3T MRI scanner with voxels of 30&#x000d7;30&#x000d7;30mm located in left and right medial prefrontal cortex. Spectral analysis with estimation of gamma-band power (30-45 Hz) were conducted. MEGA-PRESS acquisitions were analyzed with jMRUi (ver. 5.1 Alpha), levels of GLX were calculated as a ratios to creatine + phosphocreatine (GLX/Cr). Gamma-band (30-45 Hz) spectral power and GLX/Cr were compared between groups. Correlations between EEG and metabolite data were analyzed with regression model including age and chlorpromazine equivalents as covariates.</p></sec><sec id="sec6820"><title>Results</title><p>Compared to healthy controls, patients showed reduced spectral gamma-band power in 6 leads (Table). No alterations in GLX/Cr were detected. Positive correlations between altered gamma-power in all leads (except Cz) and GLX/Cr in left medial prefrontal cortex were revealed in CHR (F3: r=0.51, p=0.006; F8: r=0. 54, p=0.004; C3: r=0.37, p=0.037; Pz: r=0.51, p=0.039; P4: r=0.56, p=0.009). No correlations in HC group were found. Chlorpromazine equivalents did not correlate with GLX/Cr of gamma power in CHR group.<table-wrap position="anchor" id="tab32"><label>Table.</label><caption><p>Results of between-group comparisons corrected for multiple comparisons</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">
Lead</th><th align="center" valign="middle" rowspan="1" colspan="1">
CHR Mean&#x000b1;SD</th><th align="center" valign="middle" rowspan="1" colspan="1">
HC Mean&#x000b1;SD</th><th align="center" valign="middle" rowspan="1" colspan="1">
p
-value
</th><th align="center" valign="middle" rowspan="1" colspan="1">
F</th><th align="center" valign="middle" rowspan="1" colspan="1">
Cohen&#x02019;s d</th><th align="center" valign="middle" rowspan="1" colspan="1">
Cohen&#x02019;s d CI 95%</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">F3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97&#x000b1;0.62</td><td align="center" valign="middle" rowspan="1" colspan="1">1.4&#x000b1;0.64</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0097</td><td align="center" valign="middle" rowspan="1" colspan="1">7.2</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.69</td><td align="center" valign="middle" rowspan="1" colspan="1">-1.22&#x000a0;-0.16</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.84&#x000b1;0.61</td><td align="center" valign="middle" rowspan="1" colspan="1">1.45&#x000b1;1.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0072</td><td align="center" valign="middle" rowspan="1" colspan="1">7.8</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.71</td><td align="center" valign="middle" rowspan="1" colspan="1">-1.24&#x000a0;-0.19</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97&#x000b1;0.55</td><td align="center" valign="middle" rowspan="1" colspan="1">1.44&#x000b1;0.64</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0026</td><td align="center" valign="middle" rowspan="1" colspan="1">9.9</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.79</td><td align="center" valign="middle" rowspan="1" colspan="1">-1.32&#x000a0;-0.27</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cz</td><td align="center" valign="middle" rowspan="1" colspan="1">1.03&#x000b1;0.61</td><td align="center" valign="middle" rowspan="1" colspan="1">1.42&#x000b1;0.52</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0074</td><td align="center" valign="middle" rowspan="1" colspan="1">7.7</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.70</td><td align="center" valign="middle" rowspan="1" colspan="1">-1.22&#x000a0;-0.18</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Pz</td><td align="center" valign="middle" rowspan="1" colspan="1">1.17&#x000b1;0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">1.62&#x000b1;0.63</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0098</td><td align="center" valign="middle" rowspan="1" colspan="1">7.1</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.68</td><td align="center" valign="middle" rowspan="1" colspan="1">-1.2&#x000a0;-0.16</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">P4</td><td align="center" valign="middle" rowspan="1" colspan="1">1.04&#x000b1;0.66</td><td align="center" valign="middle" rowspan="1" colspan="1">1.53&#x000b1;0.66</td><td align="center" valign="middle" rowspan="1" colspan="1">0.0051</td><td align="center" valign="middle" rowspan="1" colspan="1">8.5</td><td align="center" valign="middle" rowspan="1" colspan="1">-0.74</td><td align="center" valign="middle" rowspan="1" colspan="1">-1.27&#x000a0;-0.22</td></tr></tbody></table><graphic xlink:href="S092493382401280X-TABU0032" position="anchor"/></alternatives></table-wrap>
</p></sec><sec id="sec6821"><title>Conclusions</title><p>The findings suggest that clinical-high risk of psychosis is associated with widespread alterations in resting-state gamma-band power. Positive correlations of such alterations with GLX/Cr and absence of such correlations in HC group are presumably indicative of disturbances in the excitation / inhibition balance in CHR individuals.</p><p>
<italic toggle="yes">This study was supported by RFBR grant 19-29-10040</italic></p></sec><sec id="sec6822"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>